The growth is due to
evolution of market owing to factors such as growth in proteomics and genomics
research, rising demand for high-quality antibodies for research
reproducibility, and increasing R&D activity and expenditure in the life
sciences industry. Fueled by the growing demand for personalized medicine and
structure-based drug design, the global research antibodies and reagents market
is expected to witness significant growth in the coming years.
The report Research Antibodies & Reagents Market is projected to reach USD 14.1
billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the
forecast period.
COVID-19 Impact: -
The COVID-19 outbreak
has boosted research activity due to efforts to understand the dynamics of the
infection. We estimate that the major share of research antibody and reagent
manufacturing, along with personalized medicine, will grow at a stable pace in
the next five years. Due to the increase in research activity, both the
availability of funding for research and the demand & manufacturing of
reagents and antibodies are expected to grow. As companies after pandemic have
scaled up their operations for testing and tracking the infection of COVID-19.
This has given a chance for growth in profits for companies operating in the
NGS and PCR markets. The growth in revenue is 5–7%, as COVID-19 testing has
increased with the use of the latest technology of genetic and molecular
testing. The shift in demand for research for COVID-19, neurobiology, and
oncology has created a huge scope for testing solutions, such as western
blotting, flow cytometry, ELISA, and drugs for researchers and laboratories.
Market Segmentation: -
Based on product, the
research antibodies market is segmented into reagents and antibodies. The
antibodies segment is expected to grow at highest CAGR in forecast period. This
is due to the research-use antibodies offer high specificity and selectivity
and are used ubiquitously in biochemical and medical research for
protein-target identification, regulatory characterization, and discovery.
Based type, the research
reagents market is segmented into primary antibodies and secondary antibodies.
The primary antibodies segment held the largest share of the global research
antibodies market in 2019.
Based type, the research
antibodies market is segmented into media &sera, stains & dyes,
fixatives, buffers, solvents, enzymes, probes and other reagents. The media
& sera reagent segment held the largest share of the global research
antibodies market in 2019.
Based on technology, the
research antibodies and reagents market is segmented into western blotting,
flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence,
Immunoprecipitation, and other technologies. Western blotting segment is
expected to grow at highest CAGR in forecast periods (2020-2025).
Based on end user, the research reagents market is segmented into the pharmaceutical & biotechnology companies, academic & research institutions and Contract Research Organizations.
Regional Analysis:-
The Asia Pacific
research antibodies and reagents market is expected to grow at the highest CAGR
from 2020 to 2025. Also, high-growth countries, such as China, India, Japan,
South Korea, Taiwan, Australia, and Singapore are the major contributors to the
Asia Pacific research antibodies and reagents market.